Australian Transportation Stock News

In February 2026, Mesoblast reported data from patients treated under the U.S. Emergency Investigational New Drug program showing that its FDA-approved cell therapy Ryoncil® (remestemcel-L-rknd) achieved similarly high survival outcomes in steroid-refractory acute graft-versus-host disease across children and adults, at different treatment lines and regardless of ruxolitinib use or resistance. The findings, which highlighted better completion of treatment and survival when Ryoncil was used...

Insurance Australia Group (ASX:IAG) has put up another set of solid headline numbers for H1 2026, with trailing twelve month revenue of about A$17.4b and basic EPS of A$0.57 coming off net income of A$1,359m, while the latest reported half in 2025 delivered revenue of A$8.7b and EPS of A$0.25 on net income of A$581m. Over the past few reported halves the company has seen revenue move from A$8.1b in H2 2024 to A$8.7b in H1 2025 and A$8.7b in H2 2025, alongside EPS shifting from A$0.21 to...

Oneview Healthcare (ASX:ONE) has put fresh numbers on the table for FY 2025, reporting first half revenue of €6.3 million and a basic EPS loss of €0.01. Trailing twelve month revenue stands at €11.6 million with a basic EPS loss of €0.016452. Over recent periods the company’s revenue has moved from €4.7 million in the first half of 2024 to €5.2 million in the second half of 2024 and then to €6.3 million in the first half of 2025. Across the same periods, half year basic EPS figures have...

CAR Group (ASX:CAR) is back in focus after its latest half year earnings, where revenue reached A$625.79 million and net profit came in at A$143.34 million, alongside a higher interim dividend. See our latest analysis for CAR Group. Despite the solid half year update and higher dividend, the share price has had a tougher run, with a 30 day share price return of a 17.67% decline and a year to date share price return of an 18.79% decline. The 1 year total shareholder return of a 32.67% decline...

Northern Star Resources (ASX:NST) has reported another solid set of numbers for H1 2026, with the latest reported half year in H2 2025 showing revenue of A$3.5b and basic EPS of A$0.68, underpinned by net income of A$833.3m. The company has seen revenue move from A$2.7b and EPS of A$0.38 in H2 2024 to A$2.9b and EPS of A$0.44 in H1 2025, then to A$3.5b and EPS of A$0.68 in H2 2025. This sets up a trailing twelve month net income of A$1.5b and EPS of A$1.16. With net profit margins running at...

In early 2026, Electro Optic Systems (EOS) issued a detailed rebuttal to US short seller Grizzly Research’s report, clarifying its cash position, explaining that a disputed US$80 million South Korean high‑energy laser contract is conditional and excluded from its confirmed A$459 million order backlog, and defending the MARSS Group acquisition. At the same time, EOS signed a collaboration agreement with Turkish defence company ROKETSAN and disclosed a conditional high‑energy laser contract in...

Pro Medicus (ASX:PME) has just posted its H1 2026 scorecard, headlined by trailing 12 month revenue of A$241.1 million alongside basic EPS of A$2.25, as the company continues to convert its imaging software footprint into solid top and bottom line figures. The company has seen revenue move from A$184.6 million to A$241.1 million across recent trailing 12 month periods, with basic EPS stepping up from A$0.94 to A$2.25 over the same horizon. Reported net profit margin has shifted sharply higher...

AMP (ASX:AMP) has put fresh numbers on the table for FY 2025, reporting first half revenue of A$1.4 billion and basic EPS of A$0.039. This helps set the tone for how the year is shaping up after a mixed FY 2024. The company reported revenue of A$1.4 billion in the first half of 2024 and a loss of A$392 million in the second half. Over the same period, basic EPS moved from A$0.0387 to A$0.0185, before reaching A$0.039 in the latest half. For investors, a key focus now is how these results...

In February 2026, Expensify, Inc. announced an expanded partnership with Xero, offering new small-business customers six months free on Xero’s Business Edition and 50% off Expensify’s annual plan for six months when signing up through each other’s platforms. By pairing cross-platform discounts with coordinated onboarding and in-app promotion, the collaboration could deepen usage across both ecosystems and tighten the link between expense management and accounting workflows. Next, we’ll...

BHP Group (ASX:BHP) is back shipping iron ore from Port Hedland after Tropical Cyclone Mitchell temporarily halted exports, while also committing more capital to large copper, gold, and silver projects in Argentina's Vicuña District. See our latest analysis for BHP Group. Those developments come as BHP’s share price, now at A$52.09, has shown firm positive momentum, with a 9.48% 1 month share price return and a 21.85% 3 month share price return, while the 1 year total shareholder return is...

Paladin Energy reported its December 2025 half-year results, with quarterly sales rising to US$102.38 million and net income to US$6.27 million, while recent equity raisings of A$300 million plus a A$100 million share purchase plan and a syndicated debt restructure bolstered its liquidity to fund Langer Heinrich and Patterson Lake South. An interesting takeaway is that despite six‑month net income of just US$0.872 million, Paladin has materially strengthened its balance sheet to support...

Commonwealth Bank of Australia has reported higher half‑year earnings to 31 December 2025, with net income rising to A$5,367 million and basic earnings per share from continuing operations lifting to A$3.237, and it has declared a fully franked interim dividend of A$2.35 per share payable on 30 March 2026. By combining record cash earnings with an increased fully franked dividend and continued investment in technology and AI, the bank is signalling confidence in its core franchise strength...

What triggered the latest move in Deep Yellow shares? Deep Yellow (ASX:DYL) has been in focus after confirming uranium mineralisation at the S Bend prospect near its Tumas Project, as well as announcing that Managing Director and CEO John Borshoff will step down immediately. See our latest analysis for Deep Yellow. At the current share price of A$2.47, Deep Yellow has seen a 22.89% 1 month share price return and a 54.86% 3 month share price return. Its 1 year total shareholder return of...

Insiders who purchased Canadian Phosphate Limited ( ASX:CP8 ) shares in the past 12 months are unlikely to be deeply...

What Evolution’s record half year means for shareholders Evolution Mining (ASX:EVN) has reported record half year numbers, with revenue of A$2,794.35 million and net profit of A$766.57 million, alongside a fully franked interim dividend of A$0.20 per share. For you as an investor, the combination of higher earnings per share, lower net debt over the past two years and a materially larger dividend sits at the centre of the current investment story. See our latest analysis for Evolution...

Neuren Pharmaceuticals (ASX:NEU) has announced a new share buy-back program, authorising repurchases of up to 6,350,631 shares, or 5% of its issued capital, through to March 2027. See our latest analysis for Neuren Pharmaceuticals. The buy-back comes after a sharp 30 day share price return of around a 30% decline and a 90 day share price return of about a 29% decline, even though the 1 year and multi year total shareholder returns remain positive and very strong. This suggests recent selling...

The Australian market has been experiencing a turbulent period, with concerns over artificial intelligence and tech sector volatility affecting investor sentiment. Despite these challenges, investors continue to seek opportunities in various sectors, including penny stocks. While the term 'penny stock' might feel outdated, it remains relevant as these smaller or newer companies can offer affordability and growth potential when backed by solid financials. Let's explore three ASX penny stocks...

Why CSL (ASX:CSL) is in focus right now CSL (ASX:CSL) is back in the spotlight after reporting an 81% drop in first half net profit, confirming its interim dividend, expanding its share buyback program, and announcing the sudden retirement of CEO Paul McKenzie. See our latest analysis for CSL. Those profit and leadership shocks have gone hand in hand with sharp share price moves, with a 1 day share price return of 6.88% decline and a 7 day share price return of 16.03% decline. The 1 year...

If you are wondering whether Woolworths Group is fairly priced or offering value right now, you are not alone. This article is all about unpacking what the current share price really reflects. The stock recently closed at A$32.21, with returns of 1.9% over 7 days, 6.8% over 30 days, 9.4% year to date, 9.6% over 1 year, and 12.8% over 5 years, while the 3 year return sits at a 2.6% decline. Recent news around Woolworths Group has focused on its position as one of Australia's largest consumer...

REA Group (ASX:REA) has put shareholder returns in focus after its latest half year earnings, pairing a higher ordinary dividend with Board approval for a share repurchase program of up to A$200 million. See our latest analysis for REA Group. Despite the buyback and higher dividend, REA Group’s recent share price return has been weak, with a 1-month share price return decline of 11.12% and a 1-year total shareholder return decline of 37.53%, while longer term total shareholder returns over 3...

Key Insights Given the large stake in the stock by institutions, Magellan Financial Group's stock price might be...

The Mach7 Technologies Limited ( ASX:M7T ) share price has softened a substantial 38% over the previous 30 days...

Brambles (ASX:BXB) has had a rough three months with its share price down 2.8%. However, a closer look at its sound...

Wiseway Group Limited ( ASX:WWG ) shareholders have had their patience rewarded with a 27% share price jump in the last...